Loss of MLH1/PMS2 expression in 81% of patients with EAC in our study is contrary to the low prevalence (3.5% to 6.6%) of MSI-H BE-associated EAC found in other studies (12,31). This evidence concerns the gene MLH1 and Barrett esophagus.